«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:

第26卷

期数:

2019年03期

页码:

141-145

栏目:

视窗2020

出版日期:

2019-05-28

文章信息/Info

作者:

孙宇航 王萍

哈尔滨医科大学人文社会科学学院

关键词:

罕见病; 法律政策; 罕见药; 医疗保险

Keywords:

Rare Diseases;  Laws and Policies;  Orphan Drugs;  Medical Insurance

DOI:

10.13912/j.cnki.chqm.2019.26.3.39

摘要:

目的通过了解国外罕见病患者医疗保障现状，为国内罕见病患者医疗保障改进提供借鉴，为完善我国罕见病立法及政策提出初步构想。方法检索2006年-2016年国外关于罕见病患者医疗保障的文献，对文献观点及结论进行统计分析。结果国外对于罕见病患者的医疗保障主要以界定罕见病内涵、提高罕见病药品可及性与医疗保险报销比重等方面作为讨论重点。结论罕见病患者医疗保障在不同国家和地区存在差异，本研究涉及鼓励罕见病科学研究、规范罕见病药物管理、增加罕见病在医疗保险体系中的占有率等若干策略

Abstract:

ObjectiveTo investigate the status of medical care for patients with rare diseases abroad to provide reference for the improvement of health care for rare diseases in China and put forward preliminary ideas for improving the legislation and policies of rare diseases in China.MethodsThis paper retrieved literatures on the medical care of patients with rare diseases from 2006 to 2016 and analyzed the literature views and conclusions.ResultsForeign medical care for rare diseases mainly focused on discussing the definition of a rare disease, improvement of the accessibility of medication and the health insurance reimbursement level etc. Conclusion There are differences in medical insurance policies for rare diseases in different countries and regions. The study may include strategies to encourage rare disease research, standardize the management of rare diseases, and increase the occupancy rate of rare diseases in the medical insurance system and several strategies etc.

常用功能

更新日期/Last Update: 2019-05-28